22 results
DEF 14A
CHRO
Chromocell Therapeutics Corp
26 Sep 24
Definitive proxy
5:08pm
responsibilities relating to executive compensation.
Our audit committee operates under a written charter that satisfies the applicable rules of the SEC … recognizes such income, subject to the limitation on the deduction of executive compensation under Section 162(m) of the Internal Revenue Code
PRE 14A
CHRO
Chromocell Therapeutics Corp
9 Sep 24
Preliminary proxy
5:30pm
compensation plans; and
making recommendations to our Board regarding any other board of director responsibilities relating to executive compensation.
Our … to the limitation on the deduction of executive compensation under Section 162(m) of the Internal Revenue Code in the case of certain executives. Section
424B3
CHRO
Chromocell Therapeutics Corp
6 Aug 24
Prospectus supplement
4:49pm
Act of 2002 (the “Sarbanes-Oxley Act”);
reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements … and registration statements; and
exemptions from the requirements of holding non-binding advisory votes on executive compensation or golden parachute
424B3
CHRO
Chromocell Therapeutics Corp
16 Apr 24
Prospectus supplement
5:49pm
disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements; and
exemptions from … the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements.
We may take advantage
424B3
3b59qsie
16 Apr 24
Prospectus supplement
5:45pm
10-K
a0mm 0h6z
16 Apr 24
Annual report
4:48pm
10-K
EX-97.1
304yh8h0
16 Apr 24
Annual report
4:48pm
424B4
a7oc8 na0ssd
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
oymaqt23oxjz5
20 Feb 24
Prospectus supplement with pricing info
5:28pm